TFFP लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (10 May 2024 @ 01:30):

Stats
आज की मात्रा	22 175.00
औसत मात्रा	37 381.00
बाजार मूल्य	6.75M
EPS	$0 ( 2024-04-02 )
अगली कमाई की तारीख	( $-2.26 ) 2024-06-04
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.180
ATR14	$0.0290 (1.33%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-18	King Thomas Braxton	Buy	3 110	Restricted stock units
2024-04-18	Patane Michael A	Buy	3 556	Restricted stock units
2024-04-18	Lee Catherine Chai-zon	Buy	3 556	Restricted stock units
2024-04-18	Mills Robert S	Buy	4 667	Restricted stock units
2024-04-18	Roberts Brandi	Buy	5 333	Restricted stock units

INSIDER POWER
71.21
Last 95 transactions
Buy: 4 806 950 \| Sell: 2 066 322

मात्रा सहसंबंध

लंबा: 0.07 (neutral)

छोटा: 1.00 (very strong)

Signal:(55.953) Expect same movement, but be aware

TFF Pharmaceuticals Inc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
MRACW	0.954
BIOL	0.949
NRBO	0.946
KBSF	0.94
SLNH	0.939
GRNV	0.935
AVCT	0.934
AYLA	0.929
TDAC	0.927
UK	0.926

10 सबसे अधिक नकारात्मक सहसंबंध
VLYPO	-0.938
BOCH	-0.931
IART	-0.923
SLGN	-0.92
MMAC	-0.919
RFEU	-0.919
LMRK	-0.918
INNV	-0.917
LOPE	-0.914
AGFS	-0.911

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

TFF Pharmaceuticals Inc सहसंबंध - मुद्रा/वस्त्र

-0.24
( neutral )

-0.64
( weak negative )

0.00
( neutral )

-0.65
( weak negative )

0.56
( weak )

0.42
( neutral )

TFF Pharmaceuticals Inc वित्तीय

Annual	2023
राजस्व:	$733 871
सकल लाभ:	$231 391 (31.53 %)
EPS:	$-11.85

FY	2023
राजस्व:	$733 871
सकल लाभ:	$231 391 (31.53 %)
EPS:	$-11.85

FY	2022
राजस्व:	$0
सकल लाभ:	$-388 221 (0.00 %)
EPS:	$-26.49

FY	2021
राजस्व:	$88.00
सकल लाभ:	$88.16 (100.00 %)
EPS:	$-0.00152

Financial Reports:

No articles found.

TFF Pharmaceuticals Inc

TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's lead drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It is also developing other dry powder products, such as cannabidiol substance for the treatment of various epilepsy syndromes, as well as anxiety, insomnia, and various pain; Inhaled SARS-CoV2 Monoclonal Antibody for the treatment of patients with COVID-19 infections; Niclosamide Inhalation Powder to treat tapeworm infections in humans, as well as COVID-19 disease; and other vaccines. The company has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs; a joint development agreement with Augmenta Bioworks, Inc. to develop inhaled SARS-CoV2 monoclonal antibody; and a licensing and collaboration agreement with UNION therapeutics A/S. The company was incorporated in 2018 and is based in Austin, Texas.